Myocardial Metabolic Effects of EPO in <i>HS-65_BV</i>.

Numbers in brackets indicate when the sample size decreased from the initial twelve animals. BW, blood withdrawal; HS, hemorrhagic shock; NS, normal saline; BR, blood reinfusion; EPO, erythropoietin; CTR, control; Ao, aorta; GCV, great cardiac vein. Values are mean ± SD. The data was analyzed using two-way repeated measures ANOVA. There were no overall significant treatment effects and no overall statistically significant interactions between treatment and time. ap≤0.05; cp≤0.001 denote significant differences vs baseline using the Holm-Sidak test for multiple comparisons showing the differences only when they occurred in one of the two groups. Myocardial Metabolic Effects of EPO in HS-65BV.